Ionis Pharmaceuticals (IONS) PT Lowered to $54 at BMO Capital Post Pelacarsen Failure
Tweet Send to a Friend
(Updated - September 8, 2026 9:24 AM EDT)
BMO Capital analyst David Lebowitz lowered the price target on Ionis ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BMO Capital analyst David Lebowitz lowered the price target on Ionis ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
